AEON Biopharma

AEON Biopharma is a biopharmaceutical company focused on the development of ABP-450, a proprietary 900 kDabotulinum toxin complex, for debilitating medical conditions. The company is dedicated to developing novel and proprietary treatment paradigms in order to improve patient outcomes and drive increased value for patients, physicians, and payers.

Domain

aeonbiopharma.com

Employees

1-10

Last Funding

$22.0M

Founded

2012

Frequently Asked Questions

What technologies does AEON Biopharma use?+

AEON Biopharma uses 16 technologies including Astra, Elementor, WordPress.

What industry is AEON Biopharma in?+

AEON Biopharma operates in the Biotechnology industry.

Where is AEON Biopharma based?+

AEON Biopharma is headquartered in United States.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026